Development of guidelines and clinical practice for breast cancer
10.3760/cma.j.issn.0529-5815.2020.02.002
- VernacularTitle: 乳腺癌诊疗指南和临床实践历程
- Author:
Zefei JIANG
1
;
Jianbin LI
2
Author Information
1. Department of Breast Cancer, the Fifth Medical Center of People′s Liberation Army General Hospital, Beijing 100071, China
2. Department of Medical Molecular Biology, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Guidebooks;
Consensus
- From:
Chinese Journal of Surgery
2020;58(2):85-90
- CountryChina
- Language:Chinese
-
Abstract:
In the past two decades, with the introduction of NCCN guidelines, the establishment of a standardized diagnosis and treatment system for breast cancer had begun. The Chinese version of the NCCN guidelines, which combines international standards and Chinese characteristics, was then developed to guide clinical practice. Since 2011, Chinese experts have entered St. Gallen International Expert Consensus Group, and to introduce the latest therapy concepts. On this basis, the Chinese Society of Clinical Oncology has developed guidelines for diagnosis and treatment in line with product accessibility and expert opinions to help clinicians choose the best treatment option. The latest Chinese Society of Clinical Oncology Breast Cancer Guideline will further contribute to the establishment of a standardized diagnosis and treatment system for breast cancer.
